We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

State Street Reports 5.4% Stake in Kosmos Energy

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 32,071,723 shares of Kosmos Energy Ltd common stock as of September 30, 2026.

Aakashdeep | 10 November 2026

Nova Ltd. Director Rani Cohen Plans 3,121-Share Sale

Nova Ltd. director Rani (Raanan) Cohen filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 3,121 ordinary shares with an aggregate market value of $1,040,042.04, to be executed on Nasdaq through Oppenheimer & Co. Inc.

Aakashdeep | 10 November 2026

KULR Technology Q3 2026: Revenue Rises to $7.4M

KULR Technology Group, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended September 30, 2026, reporting results for its thermal management and energy storage technology business.

Manish Choudhary | 10 November 2026

Worthington Enterprises Holds Investor and Analyst Day Nov. 10

Worthington Enterprises, Inc. filed a Form 8-K on November 10, 2026, disclosing under Item 7.01 (Regulation FD) that it posted an Investor and Analyst Day presentation and issued a related news release on that same date.

Nitish Kishor | 10 November 2026

State Street Reports 5.6% Stake in Intellia Therapeutics

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 7,809,060 shares of Intellia Therapeutics Inc common stock as of September 30, 2026.

Nitish Kishor | 10 November 2026

State Street Reports 4.8% Stake in Iovance Biotherapeutics

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 21,695,003 shares of Iovance Biotherapeutics Inc common stock as of September 30, 2026.

Manish Choudhary | 10 November 2026

State Street Discloses 6.5% Stake in International Paper

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 34,166,190 shares of International Paper Co common stock as of September 30, 2026.

Anjali Anand | 10 November 2026

State Street Reports 5% Stake in Intuitive Machines

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 8,656,543 shares of Intuitive Machines Inc common stock as of September 30, 2026.

Nitish Kishor | 10 November 2026

MaxCyte to Acquire Akron BioProducts for $105M Cash Plus Stock

MaxCyte, Inc. filed an 8-K with the SEC on November 10, 2026, disclosing that it entered into a Securities Purchase Agreement on November 9, 2026, to acquire all outstanding equity interests of Akron BioProducts LLC from affiliates of Arcline Investment Management.

Aditi Sarkar | 10 November 2026

State Street Discloses 5.9% Stake in indie Semiconductor

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 12,902,835 shares of indie Semiconductor Inc common stock, representing 5.9% of the class, as of September 30, 2026.

Shwetambri Chauhan | 10 November 2026
Support

Hi! How can we help you today?

Loading…